IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2003;44:3802-3809.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0227
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akimoto, Y.
Right arrow Articles by Hirano, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akimoto, Y.
Right arrow Articles by Hirano, H.

Elevated Expression of O-GlcNAc–Modified Proteins and O-GlcNAc Transferase in Corneas of Diabetic Goto-Kakizaki Rats

Yoshihiro Akimoto,1 Hayato Kawakami,1 Koji Yamamoto,2 Eiji Munetomo,2 Tetsuo Hida,3 and Hiroshi Hirano1,4

1From the Departments of Anatomy and 3Ophthalmology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan; 2Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama, Japan; and the 4Nittai Jusei Medical College for Judo Therapeutics, Yoga, Setagaya, Tokyo, Japan.

PURPOSE. The hexosamine biosynthetic pathway is one of the possible mechanisms involved in diabetic keratopathy. The purpose of this study was to examine the role of O-glycoside–linked N-acetylglucosamine (O-GlcNAc) modification of proteins in the pathogenesis of diabetic keratopathy in the Goto-Kakizaki (GK) rat, which has spontaneous development of diabetes.

METHODS. An anti-O-GlcNAc antibody, an anti-O-GlcNAc transferase antibody, and digoxigenin (DIG)-labeled cRNA probes were used to examine the localization of O-GlcNAc–modified proteins, O-GlcNAc transferase protein and mRNA in the corneas of diabetic GK rats and in those of nondiabetic Wistar rats. The corneas from Wistar rats were organ cultured in control medium or in medium containing 100 µM O-(2-acetamide-2-deoxy-D-glucopyranosylidene) amino-N-phenyl-carbamate (PUGNAc), an inhibitor of O-GlcNAcase, the enzyme that removes O-GlcNAc from proteins. The morphologic changes were examined by electron microscopy.

RESULTS. In normal corneas, immunoreactive O-GlcNAc and O-GlcNAc transferase were observed in the epithelial, endothelial, and stromal cells. In the diabetic corneas, their immunoreactivities in the epithelium were increased in intensity. Morphologically, the number of hemidesmosomes in the epithelial basal cells was lower than that in those cells from the nondiabetic rats. In some areas, the basement membrane had detached from the epithelial basal cells. The PUGNAc treatment of Wistar rat corneas increased the level of O-GlcNAc immunoreactivity and caused a decrease in the number of hemidesmosomes and the detachment of corneal epithelial cells from the basement membrane.

CONCLUSIONS. The elevated expression of O-GlcNAc–modified proteins and O-GlcNAc transferase may play a causative role in the corneal epithelial disorders of diabetic GK rats.




This article has been cited by other articles:


Home page
 IOVSHome page
M. Wakuta, N. Morishige, T.-i. Chikama, K. Seki, T. Nagano, and T. Nishida
Delayed Wound Closure and Phenotypic Changes in Corneal Epithelium of the Spontaneously Diabetic Goto-Kakizaki Rat
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 590 - 596.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
Y. Akimoto, G. W. Hart, L. Wells, K. Vosseller, K. Yamamoto, E. Munetomo, M. Ohara-Imaizumi, C. Nishiwaki, S. Nagamatsu, H. Hirano, et al.
Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats
Glycobiology, February 1, 2007; 17(2): 127 - 140.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Marz, J. Stetefeld, K. Bendfeldt, C. Nitsch, J. Reinstein, R. L. Shoeman, B. Dimitriades-Schmutz, M. Schwager, D. Leiser, S. Ozcan, et al.
Ataxin-10 Interacts with O-Linked beta-N-Acetylglucosamine Transferase in the Brain
J. Biol. Chem., July 21, 2006; 281(29): 20263 - 20270.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
D. C. Love and J. A. Hanover
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Sci. Signal., November 29, 2005; 2005(312): re13 - re13.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Saghizadeh, A. A. Kramerov, J. Tajbakhsh, A. M. Aoki, C. Wang, N.-N. Chai, J. Y. Ljubimova, T. Sasaki, G. Sosne, M. R. J. Carlson, et al.
Proteinase and Growth Factor Alterations Revealed by Gene Microarray Analysis of Human Diabetic Corneas
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3604 - 3615.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. Hu, D. Belke, J. Suarez, E. Swanson, R. Clark, M. Hoshijima, and W. H. Dillmann
Adenovirus-Mediated Overexpression of O-GlcNAcase Improves Contractile Function in the Diabetic Heart
Circ. Res., May 13, 2005; 96(9): 1006 - 1013.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology